Rethinking business model for drug discovery, post-COVID
Year of publication: |
2022
|
---|---|
Authors: | Mishra, Bud ; Qi, Qianru |
Published in: |
Review of business : interdisciplinary journal on risk and society. - New York, NY, ISSN 0034-6454, ZDB-ID 634068-4. - Vol. 42.2022, 2, p. 1-20
|
Subject: | blockchain | cancer megafund | economics of science | financial engineering | non-fungible token (NFT) | peer to peer | Geschäftsmodell | Business model | Krebskrankheit | Cancer | Financial Engineering | Financial engineering | Blockchain |
-
Analysis of platform business and secure business intelligence
Mishra, Shrutika, (2022)
-
The technology of decentralized finance (DeFi)
Auer, Raphael A., (2023)
-
On the profitability of selfish blockchain mining under consideration of ruin
Albrecher, Hansjörg, (2022)
- More ...
-
Rethinking Business Model for Drug Discovery, Post-COVID
Mishra, Bud, (2022)
-
Investigating Causal Relationships in Stock Returns with Temporal Logic Based Methods
Kleinberg, Samantha, (2010)
-
Compliance signaling games : toward modeling the deterrence of insider threats
Casey, William, (2016)
- More ...